Available Technologies

Browse Penn-owned technologies available for licensing.


Search Results - xianxin hua

2 Results Sort By:
Antibodies for Targeting CAR-T Cells to Neuroendocrine Tumors
Neuroendocrine tumors (NETs) pose serious threats to patients’ well-being as malignant diseases, and most patients with metastatic NETs succumb to the disease. Using Sequential Tumor-related Antibody and antigen Retrieving (STAR) technology Dr. Xianxin Hua, MD, PhD at the University of Pennsylvania Medical School and his team have identified ...
Published: 3/1/2019   |   Inventor(s): Xianxin Hua
Category(s): Diagnostics, Imaging, Therapeutics & Vaccines
Antibody Discovery Platform for CAR-T Cell Targeting and Drug Conjugation
Screening platform for identification of potent and specific nanobodies for (i) directing CAR-T cells to cancer cells, (ii) drug conjugation, or (iii) tumor imaging or diagnosis.InventorXianxin Hua, M.D., Ph.D.Identification of antibodies capable of mediating CAR-T killing is challenging due to several reasons. First, the antibody has to have certa...
Published: 3/1/2019   |   Inventor(s): Xianxin Hua
Category(s): Research Tools & Reagents, Therapeutics & Vaccines